ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer

Abstract

Despite androgen dependence in a majority of castration-resistant prostate cancers, some cancer cells are independent of androgen receptor (AR) function, a feature of heterogeneity in prostate cancer. One of the aggressive variants of prostate cancer that are AR independent is neuroendocrine prostate cancer (NEPC). This manuscript will focus on the new finding of human one cut domain family member 2 (ONECUT2) transcription factor and its role in castration resistance, especially in NEPC.

Keywords

Prostate cancers / castration resistant / ONECUT2 / androgen receptor-independence / neuroendocrine differentiation

References

[1] Siegel RL,Fuchs HE.Cancer statistics, 2021.CA Cancer J Clin2021;71:7-33

[2] Watson PA,Sawyers CL.Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.Nat Rev Cancer2015;15:701-11 PMCID:PMC4771416

[3] Aggarwal R,Small EJ.Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes.J Natl Compr Canc Netw2014;12:719-26

[4] Rickman DS,Demichelis F.Biology and evolution of poorly differentiated neuroendocrine tumors.Nat Med2017;23:1-10

[5] Rotinen M,Yang J.ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.Nat Med2018;24:1887-98 PMCID:PMC6614557

[6] Guo H,Ahmed M.ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019;10:278 PMCID:PMC6336817

[7] Kropp PA.Onecut transcription factors in development and disease.Trends Dev Biol2016;9:43-57 PMCID:PMC5176019

[8] Jacquemin P,Rousseau GG.OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6.J Biol Chem1999;274:2665-71

[9] Lu T,Yu Y.Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.Cancer Sci2018;109:2221-34 PMCID:PMC6029829

[10] Chen J,Sun B,Du C.ONECUT2 accelerates tumor proliferation through activating ROCK1 expression in gastric cancer.Cancer Manag Res2020;12:6113-21 PMCID:PMC7398892

[11] Sun Y,Liu X.Correction to: miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.Mol Cell Biochem2021;476:3215-6 PMCID:PMC8496573

[12] Zhang J,Zeng Z.Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.Oncotarget2015;6:42040-52 PMCID:PMC4747208

[13] Ma Q,Li H.ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression.Sci Rep2019;9:20021 PMCID:PMC6934839

[14] Lapuk AV,Wyatt AW.From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.J Pathol2012;227:286-97 PMCID:PMC3659819

[15] Akamatsu S,Lin D.The placental gene PEG10 promotes progression of neuroendocrine prostate cancer.Cell Rep2015;12:922-36

[16] Meng F,Bhupathi D.Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.Mol Cancer Ther2012;11:740-51